Physician profile
Megan E Moeding
NPI 1609330091
$5,479.07
in general payments reported to CMS, 2019-2025
14 companies · $2,638 in 2025
The $2,638 reported for 2025 was more than what 97% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $15.02 · 2022: $106 · 2023: $435 · 2024: $2,284 · 2025: $2,638.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,491 · Travel and Lodging: $1,866.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,491.23 |
| Travel and Lodging | $1,866.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Impulse Dynamics (USA) INC. | $1,332.51 | 2025 | Optimizer |
| Boston Scientific Corporation | $1,144.08 | 2024 | Watchman Flx |
| Abbott Laboratories | $1,122.74 | 2023-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Cardiomems |
| Abiomed | $637.81 | 2024-2025 | Impella |
| Cvrx, INC. | $453.08 | 2024-2025 | Barostim Neo System |
| Actelion Pharmaceuticals US, INC. | $408.74 | 2022-2025 | Opsumit, Uptravi |
| Medtronic, INC. | $85.63 | 2024-2025 | Corevalve Evolut R |
| E.R. Squibb & Sons, L.L.C. | $78.61 | 2022-2024 | Camzyos |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $61.07 | 2021-2023 | Lifevest |
| Novartis Pharmaceuticals Corporation | $51.46 | 2024 | |
| Heartflow, INC. | $36.76 | 2024 | |
| Pfizer INC. | $29.56 | 2024-2025 | |
| United Therapeutics Corporation | $21.55 | 2024 | Remodulin, Tyvaso, Orenitram |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.47 | 2025 | Jardiance |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Megan Moeding listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.